• Given the importance of drug-resistant Klebsiella pneumoniae and Escherichia coli strains in hospitalacquired infections, the aim of this study was to determine the characteristics of ESBL, AmpC, and carbapenemase-producing isolates. Coexistence of AmpC, ESBL, and carbapenemase genes was observed in some isolates. Implementing up-to-date strategies against such organisms is warranted. 
Introduction
Drug resistance in gram-negative bacteria is a worldwide challenge [1] . Major resistance to gram-negative pathogens is related to Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa [2] . In the Enterobacteriaceae family, Klebsiella pneumoniae and Escherichia coli have notable drug resistance. Also, they are the common cause of hospital-and community-acquired infections [3, 4] .
The wide distribution of extended-spectrum β-lactamases (ESBLs) amongst Enterobacteriaceae has been attributed to the over-or misuse of these antibiotics [5] . ESBLs are able to hydrolyze various types of β-lactam antibiotics, including cephalosporins and monobactams. Therefore, treating infections caused by ESBL-producing bacteria has become a complicated issue [5, 6] . Dissemination of hospital-acquired infections can be prevented via early detection of infections caused by such microorganisms [7] .
Carbapenems have been considered as the treatment of choice for ESBL-producing gram-negative bacterial infections. Carbapenemase-producing strains cause serious infections in hospitalized patients and are associated with mortality [8] ; hence, the use of molecular techniques could be helpful in accurately diagnosing infections caused by ESBL-and carbapenemase-producing organisms.
Drug-resistant strains of K. pneumoniae and E. coli in hospital-acquired infections are important [9] ; thus, the aim of the present study was to determine the phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing isolates of K. pneumoniae and E. coli obtained from hospital-associated infections in Tehran and Ilam (Iran).
Materials and Methods

Bacterial Strains
A total of 90 K. pneumoniae and 65 E. coli isolates were obtained from various infections of hospitalized patients between April 2016 and March 2017 in Tehran and Ilam. Phenotypic and biochemical identification of bacterial isolates was performed according to standard methods [10] .
Phenotypic Screening of ESBL, AmpC, and Carbapenemase Enzymes All isolates were initially screened for ESBL production by a combined disk method according to the guidelines of the Clinical Laboratory Standards Institute (CLSI) [11] . Briefly, susceptibility to cefotaxime (30 μg), cefotaxime/clavulanate (30/10 μg), ceftazidime (30 μg), and ceftazidime/clavulanate (30/10 μg) (Mast Co., UK) was determined on Müller-Hinton agar (Merck Co, Germany). ESBL-producing strains were recognized by an at least 5-mm increase in zone diameter around cefotaxime/clavulanate and ceftazidime/clavulanate disks in comparison with disks without clavulanic acid. E. coli ATCC 35218 was used as the control strain [11] .
Cefoxitin disks (30 μg) were used to screen AmpC-producing isolates according to CLSI recommendations [11] . A cefoxitincloxacillin double-disk synergy test was carried out to confirm AmpC production, as previously described [12] .
The modified Hodge test (MHT) was performed to screen carbapenemase-producing isolates [11] . K. pneumoniae ATCC BAA-1705 and BAA-1706 were used as MHT-positive and -negative controls [11] .
Detection of ESBL-, AmpC-, and Carbapenemase-Related Genes
Polymerase chain reaction was performed using specific primers to detect genes encoding ESBLs (bla TEM , bla SHV , bla CTX-M , and bla PER ), AmpC (bla ACC , bla DHA , bla EBC , bla FOX , bla MOX , and bla CIT ), and carbapenemase (bla IMP , bla VIM , bla NDM , bla KPC , and bla OXA-48-like ), as previously described [13] [14] [15] [16] [17] . The products were separated by electrophoresis in 1% agarose gel with 1× TBE (Tris/ borate/EDTA) buffer, stained with safe stain load dye (CinnaGen Co., Tehran, Iran) and visualized under ultraviolet illumination.
Statistical Analysis
The distribution of resistance genes among resistant and susceptible isolates was calculated using χ 2 and Fisher's exact tests for each gene. p values ≤0.05 were considered to be statistically significant. K. pneumoniae and 18 (27.7%) E. coli strains produced carbapenemase.
Results
Phenotypic
Molecular methods showed that 36 (40%) K. pneumoniae isolates harbored at least 1 of the ESBL-related genes. Distribution of these genes among K. pneumoniae strains were bla TEM 23.3%, bla SHV 21.1%, and bla CTX-M 11.1%. Presence of bla TEM and bla SHV genes in ESBL-producing K. pneumoniae isolates was statistically significant (p < 0.05). In addition, 24 (36.9%) E. coli isolates were ESBL positive. The prevalence of bla TEM and bla SHV genes was 16.9%, and bla CTX-M was observed in 21.5% of isolates. The bla PER gene was not detected in any of the strains. The bla CTX-M gene was more prevalent in E. coli isolates which were ESBL producers (Table 1) .
AmpC-associated genes were detected amongst 22 (24.4%) K. pneumoniae isolates. bla DHA , bla CIT , and bla EBC were found among 16.6, 5.5, and 13.3% of K. pneumoniae strains, respectively. bla DHA prevalence in AmpC-positive K. pneumoniae isolates was statistically significant (p < 0.05). Furthermore, 9 (13.8%) of the E. coli isolates carried AmpC genes, and the distribution percentages of bla DHA , bla CIT , and bla EBC were 6.1, 3, and 4.6%, respectively. All the strains were negative for bla ACC , bla FOX , and bla MOX (Table 2) .
Carbapenemase-related genes were detected in 34 (37.8%) K. pneumoniae isolates. The prevalence rates of these genes were bla VIM 33.3%, bla OXA-48-like 14.4%, and bla IMP 1.1%. Thirteen (20%) E. coli isolates were carbapenemase positive. bla VIM and bla OXA-48-like were observed in 12.3 and 20% of isolates, respectively. No bla IMP gene was detected in E. coli strains. bla NDM and bla KPC genes were not found in any of the bacterial isolates. bla VIM and bla OXA-48-like gene distribution was significantly different (p < 0.05) among K. pneumoniae and E. coli isolates (Table 3) . Values are presented as n (%). * p < 0.05. Values are presented as n (%). * p < 0.05. 
Discussion
In the present study, the prevalence of ESBL-, AmpC-, and carbapenemase-associated genes were investigated by phenotypic and genotypic methods in clinical isolates of K. pneumoniae and E. coli. According to the phenotypic results, the prevalence of ESBL-producing K. pneumoniae and E. coli was notable. The genotypic method confirmed the phenotypic method results, except for 1 E. coli strain. Although this isolate harbored 1 ESBL-related gene, it did not show phenotypic resistance. Similarly, unexpressed ESBL genes in antibiotic-susceptible isolates were previously reported [18] . Horizontal gene transfer to other bacteria is possible via such strains [18] .
Notable frequencies of ESBL-producing K. pneumoniae and E. coli strains were reported in Iran [19, 20] . It seems that the prevalence of ESBL-producing gram-negative bacteria is increasing in the country [20] .
In the present study, 8 K. pneumoniae isolates carried 2 ESBL genes, and 3 isolates harbored 3 ESBL genes simultaneously. Moreover, the simultaneous presence of 2 and 3 ESBL genes was observed in 6 and 3 strains of E. coli, respectively. The copresence of ESBL genes among clinical E. coli isolates was previously stated [21] .
In the present study, AmpC screening and confirmatory phenotypic tests produced different results. Similar to a previous study, a high rate of false-negative results was reported by phenotypic detection methods for AmpC [13] . In our study, AmpC-producing K. pneumoniae strains were higher than in a previous report from Iran [22] . However, a notable frequency of AmpC-producing K. pneumoniae isolates (43%) was reported among burnt patients [13] . Dissemination of AmpC β-lactamases between near half of clinical gramnegative bacilli has been reported [13, 23, 24] . In the present study, 6 AmpC-producing K. pneumoniae isolates carried bla DHA and bla EBC simultaneously, and copresence of bla DHA , bla EBC , and bla CIT was observed in 2 isolates. Recently, the coexistence of AmpC β-lactamase genes in K. pneumoniae was reported for the first time [13] . To eradicate AmpC-producing bacteria, carbapenems can be used as primary agents, but AmpC β-lactamases might increase the MIC values of carbapenems and confer resistance to the carbapenem family [13, 25] .
A frequent gene among carbapenemase-producing K. pneumoniae was bla VIM , but only 1 harbored the bla IMP gene. Similarly, in a previous study, the bla VIM gene was more frequent than the bla IMP gene [26] . The bla KPC and bla NDM genes were not detected in any of the investigated strains, while the presence of bla KPC was notable in K. pneumoniae isolates in Iran [27] . Also, in a study by Hosseinzadeh et al. [28] Our results indicated that some resistance genes were present amongst the resistant strains, which was statistically significant (p < 0.05). These appear to be the most frequent ESBL-, AmpC-, and carbapenemase-related genes in our region (Tables 1-3) . Coexistence of ESBL, AmpC, and metallo-β-lactamases was reported amongst A. baumannii strains in 2013 [29] . Pokhrel et al. [30] showed the copresence of ESBLs and carbapenemase in clinical E. coli isolates in Nepal.
The current study shows that 2 K. pneumoniae isolates simultaneously carried 2 ESBL (bla CTX-M , bla TEM / bla CTX-M , bla SHV ), 2 AmpC (bla DHA and bla EBC ), and 2 carbapenemase genes (bla VIM and bla OXA-48-like ). Moreover, coexistence of 3 ESBL (bla CTX-M , bla TEM , and bla SHV ), 1 AmpC (bla DHA ), and 3 carbapenemase genes (bla VIM , bla OXA-48-like , and bla IMP ) was seen in 1 of the studied isolates.
Conclusion
For the first time, we reported the occurrences of ESBL, AmpC, and carbapenemase genes in K. pneumoniae strains in Iran. In the present study, 2 isolates simultaneously carried 2 ESBL genes, 2 AmpC, and 2 carbapenemase genes. Moreover, coexistence of 3 ESBL, 1 AmpC, and 3 carbapenemase genes was observed in 1 K. pneumoniae isolate. Therefore, K. pneumoniae can be considered as a major pathogen and important hazard for public health. Up-to-date treatment with combination therapy and/or new antimicrobial agents, for example, might be helpful against such drug-resistant organisms.
